|
TMEM184C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64579461170433E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.39397390799923E-12 |
| Normal-vs-Stage2 |
8.15030000000938E-05 |
| Normal-vs-Stage3 |
2.23069999999437E-05 |
| Normal-vs-Stage4 |
4.257800E-02 |
| Stage1-vs-Stage2 |
7.784600E-01 |
| Stage1-vs-Stage3 |
5.302000E-01 |
| Stage1-vs-Stage4 |
4.335400E-01 |
| Stage2-vs-Stage3 |
7.798400E-01 |
| Stage2-vs-Stage4 |
5.379200E-01 |
| Stage3-vs-Stage4 |
6.666600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.53921361504217E-14 |
| Normal-vs-AfricanAmerican |
3.74970055005974E-11 |
| Normal-vs-Asian |
2.167600E-04 |
| Caucasian-vs-AfricanAmerican |
7.871000E-01 |
| Caucasian-vs-Asian |
9.572400E-01 |
| AfricanAmerican-vs-Asian |
8.692800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
2.03889999994544E-06 |
| Male-vs-Female |
3.523200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.059100E-03 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
5.03860286826807E-11 |
| Normal-vs-Extreme_Obese |
2.398000E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.627450E-01 |
| Normal_Weight-vs-Obese |
7.023600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.399200E-01 |
| Extreme_Weight-vs-Obese |
3.255900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.977400E-01 |
| Obese-vs-Extreme_Obese |
8.057800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.998500E-02 |
| Normal-vs-Age(41-60Yrs) |
9.37472321993482E-13 |
| Normal-vs-Age(61-80Yrs) |
2.20046203480706E-13 |
| Normal-vs-Age(81-100Yrs) |
1.19300014311818E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.685780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.542990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.922500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.020400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.210820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.299420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.2225999999903E-05 |
| Normal-VS-KIRP CIMP |
7.232200E-01 |
| Normal-VS-Unclassified PRCC |
1.72821999999684E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.257600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.803700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.606070E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.393430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.998200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.588400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67110769666579E-12 |
| Normal-vs-N1 |
2.602600E-03 |
| Normal-vs-N2 |
2.390400E-01 |
| N0-vs-N1 |
1.227540E-02 |
| N0-vs-N2 |
8.043600E-01 |
| N1-vs-N2 |
5.627800E-01 |
|
|
